Vendor review
Zenith Jove Peptide ZJ reviews
Zenith Jove Peptide ZJ reviews from 87 independent lab tests (Retatrutide, Tirzepatide and BPC-157): grade A, purity and fill accuracy. Is Zenith Jove Peptide ZJ legit? See what its vials showed.
What the lab tests show
87 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 6, 2026 | Retatrutide | 100 % | 42.4541 mg of 30 mg (42 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 18.4 mg of 20 mg (-8 %) | Pass | View |
| Sep 17, 2026 | BPC-157 | 99.9 % | 9.6 mg of 10 mg (-4 %) | Pass | View |
| Aug 18, 2026 | Retatrutide | 99.7 % | 10 mg of 10 mg (0 %) | Pass | View |
| Aug 18, 2026 | Retatrutide | 99 % | 21.9 mg of 20 mg (10 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 8.6 mg of 10 mg (-14 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 19.2 mg of 20 mg (-4 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Aug 4, 2026 | Retatrutide | 99.9 % | 3.32 mg of 1 mg (232 %) | Pass | View |
| Jul 23, 2026 | PT-141 | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jul 23, 2026 | Tesamorelin | 98.8 % | 11 mg of 10 mg (10 %) | Pass | View |
| Jul 23, 2026 | Cagrilintide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jul 23, 2026 | Melanotan II | 99.9 % | 9.97 mg of 10 mg (0 %) | Pass | View |
| Jul 23, 2026 | PT-141 | 99.9 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Jul 23, 2026 | Tesamorelin | 99.2 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Jul 23, 2026 | Melanotan II | 99.9 % | 9.81 mg of 10 mg (-2 %) | Pass | View |
| Jul 23, 2026 | Cagrilintide | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jul 22, 2026 | Retatrutide | 99.9 % | 64.9 mg of 60 mg (8 %) | Pass | View |
| Jul 22, 2026 | Tirzepatide | 99.2 % | 36 mg of 30 mg (20 %) | Pass | View |
| Jul 22, 2026 | Retatrutide | 99.9 % | 63.9 mg of 60 mg (7 %) | Pass | View |
| Jul 22, 2026 | Tirzepatide | 99.3 % | 35.3 mg of 30 mg (18 %) | Pass | View |
| Jul 22, 2026 | BPC-157 | 99.9 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jul 22, 2026 | BPC-157 | 99.9 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Jul 22, 2026 | GHK-Cu | 99.6 % | 119 mg of 100 mg (19 %) | Pass | View |
| Jul 22, 2026 | GHK-Cu | 99.6 % | 117 mg of 100 mg (17 %) | Pass | View |
| Jul 1, 2026 | Retatrutide | 99.9 % | 26.9 mg of 30 mg (-10 %) | Pass | View |
| Jun 8, 2026 | TB-500 | 99.7 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Jun 8, 2026 | BPC-157 | 99.8 % | 9.4 mg of 10 mg (-6 %) | Pass | View |
| May 25, 2026 | Retatrutide | 99.8 % | 31 mg of 30 mg (3 %) | Pass | View |
| May 6, 2026 | Retatrutide | 99.9 % | 19.4 mg of 20 mg (-3 %) | Pass | View |
| May 5, 2026 | Retatrutide | 99.9 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| May 5, 2026 | Retatrutide | 99.9 % | 9.81 mg of 10 mg (-2 %) | Pass | View |
| May 5, 2026 | TB-500 | 98.5 % | 5.06 mg of 5 mg (1 %) | Pass | View |
| May 5, 2026 | BPC-157 | 99.9 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| May 5, 2026 | Tirzepatide | 99.9 % | 29.5 mg of 30 mg (-2 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 27.2 mg of 30 mg (-9 %) | Pass | View |
| Apr 27, 2026 | Tirzepatide | 99.7 % | 21.4 mg of 15 mg (43 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Apr 23, 2026 | TB-500 | 95.1 % | 4.83 mg of 5 mg (-3 %) | Pass | View |
| Apr 23, 2026 | BPC-157 | 99.9 % | 9.13 mg of 10 mg (-9 %) | Pass | View |
| Apr 23, 2026 | GHK-Cu | 99.9 % | 132.4 mg of 100 mg (32 %) | Pass | View |
| Mar 29, 2026 | Retatrutide | 99.7 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Mar 25, 2026 | Retatrutide | 99.9 % | 21.4 mg of 20 mg (7 %) | Pass | View |
| Mar 21, 2026 | GHK-Cu | 99.7 % | 53.6 mg of 50 mg (7 %) | Pass | View |
| Mar 21, 2026 | BPC-157 | 99.8 % | 12.1 mg of 10 mg (21 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 29 mg of 30 mg (-3 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 19.8 mg of 20 mg (-1 %) | Pass | View |
| Mar 13, 2026 | Tirzepatide | 99.8 % | 21.2 mg of 20 mg (6 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 51.6 mg of 50 mg (3 %) | Pass | View |
| Mar 3, 2026 | Tirzepatide | 98.8 % | 19.6 mg of 15 mg (31 %) | Pass | View |
| Mar 2, 2026 | Tesamorelin | 99.51 % | 9.11 mg of 10 mg (-9 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.9 % | 9.91 mg of 10 mg (-1 %) | Pass | View |
| Mar 2, 2026 | TB-500 | 99.9 % | 9.28 mg of 10 mg (-7 %) | Pass | View |
| Mar 2, 2026 | BPC-157 | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.9 % | 9.88 mg of 10 mg (-1 %) | Pass | View |
| Feb 26, 2026 | GHK-Cu | 99.77 % | 49.4 mg of 50 mg (-1 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Feb 26, 2026 | Tirzepatide | 99.02 % | 39.8 mg of 40 mg (-1 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.81 % | 55.7 mg of 50 mg (11 %) | Pass | View |
What Zenith Jove Peptide ZJ sells
No current listings on record.
About Zenith Jove Peptide ZJ
https://glp1forum.com/threads/zj-latest-coa.7626/ https://www.tiktok.com/@zenith.jove